1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This grant may no longer be accepting applications.
The description indicates applications may be closed. Check the funder's website to confirm availability before applying.
Visit funder's website →This listing may be outdated. Verify details at the official source before applying.
Find similar grantsAFAR Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76) is sponsored by American Federation for Aging Research. Supports clinically trained early‑stage investigators in aging research career development.
Get alerted about grants like this
Save a search for “American Federation for Aging Research” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The Paul B.
Beeson Emerging Leaders Career Development Award in Aging (K76) - American Federation for Aging Research Ask the Expert Interviews 2025 Grantee Spotlight Interviews Dorothy Dillon Eweson Lecture Series Administrative Guidelines Things to Consider When Applying Funding Updates Newsletter by funding Grant Programs and Fellowships by guiding studies such as the FAST Initiative , the SuperAgers Initiative , and the TAME Trial by supporting the infrastructure of three NIA Initiatives and leading the Amplifying Geroscience Initiative .
Top Breakthroughs driven by AFAR Experts Delaying Disease by Targeting Aging Saving Costs by Extending Healthspan What are the Hallmarks of Aging? What is the Longevity Dividend? Why AFAR, Why Aging Research Clarence Pearson Fellowship NIA Infrastructure Support The SuperAgers Initiative Amplifying Geroscience Initiative Breakthroughs by AFAR Experts What are the Hallmarks of Aging?
What is the Longevity Dividend? Ask the Expert Interviews What is Geroscience? 2025 AFAR Awards of Distinction The Paul B.
Beeson Emerging Leaders Career Development Award in Aging (K76) The National Institute on Aging (NIA), the American Federation for Aging Research, and the John A. Hartford Foundation, are collaborating on this initiative to develop of a cadre of talented scientists prepared and willing to take an active leadership role in transformative change that will lead to improved health care outcomes.
Emerging leaders are clinically trained (primarily physician) early-stage investigators who have begun to establish research careers and have shown signs of leadership potential who will use this award to further develop the tools, skills and resources to have a significant impact in their field of expertise.
The National Institute on Aging is pursuing this initiative to recruit talented new investigators who have begun to establish research programs and through this award will be ready to assume leadership roles in their field of expertise and well poised to change theory, practice and health outcomes related to the health of older individuals.
Unlike other mentored K awards candidates for this award must have received competitively awarded research support as a PD/PI at the faculty level and have had prior leadership responsibilities in the clinical or research domain. It is anticipated that seven to ten awards will be granted in 2027. Each award is up to 5 years, with up to $225,000 in direct costs per year.
Please view the Grant Opportunity Forecast here , we will update as we know more. Deadline: estimated to be June 13, 2026 for 2027 funding Read this description of the Beeson Program on the NIA website that has helpful information on eligibility and applying. All scientific/research inquiries should be directed to: National Institute on Aging (NIA) Email: NIAtraining@nih.
gov History of the Beeson Program The Beeson program had its impetus in a series of Institute of Medicine reports that, beginning in 1978, highlighted a growing need for physicians trained in aging-related issues. After the 1993 report called for more support of geriatrics research and training, Donna Regenstreif, PhD, Senior Program Officer of The John A.
Hartford Foundation; Margaret Mahoney, then-President of The Commonwealth Fund; and Ray Handlan, Senior Advisor of The Atlantic Philanthropies, began discussing joint strategies for addressing the shortage of physicians interested in aging and dedicated to teaching, research, and practice. In 1994, a group of foundations and nonprofit organizations launched the Paul B.
Beeson Physician Faculty Scholars in Aging Research Program, now known as the Paul B. Beeson Career Development Awards in Aging Research Program. This group set out a large award—$450,000 over three years—and named the program after one of medicine's leading physician-scientists.
It gathered some of the most talented senior leaders in geriatrics and aging research to oversee the award winners' selection. The intent was to create a dynamic new cadre of physician-scientists capable of developing breakthrough research, committed to mentoring and teaching the next generation of physicians about the care of older adults, and able to provide needed leadership for the field.
In 2004, the National Institute on Aging (NIA) added its support to the program, expanding the size of the award to $600,000 to $800,000 for a three- to five-year period. NIA and the American Federation for Aging Research currently share administrative responsibilities for the program, with AFAR conducting the Beeson annual meeting.
This distinguished leader in medicine, who passed away in 2006 at the age of 97, exemplified the word "physician" — accomplished in the art of healing and the treatment of disease. His contributions as a scientist, clinician, and teacher have greatly expanded knowledge and understanding of the human condition, and in pursuing his work, he never lost focus on the importance of care in serving people.
Dr. Beeson was Chairman of Medicine at Emory and Yale Medical Schools, Nuffield Professor at Oxford University and Professor and distinguished VA Physician at the University of Washington. He chaired the first Institute of Medicine study on "Aging and Medical Education" in 1978. His leadership as an editor of the Cecil Textbook of Medicine greatly influenced medical education.
From his research and patient care base, he grew increasingly interested in the process of aging. This interest led to a commitment that included his editorship of the Journal of the American Geriatrics Society. He profoundly influenced the career paths of many young physicians, several of whom now form the core leadership in geriatric medicine.
Dr. Beeson was, in short, a physician who exemplified the William Osler tradition of excellence. Read more about Dr. Beeson Download 2019 Beeson Report Explore the research and insights of the 2017 Beeson Scholars in the most recent Beeson Report. To explore previous Beeson Scholars' research and insights, download a range of archived Beeson Reports below.
Questions about the Beeson Program? For additional support, please contact AFAR's grants team at 212. 703.
9977 or email below. Funding Updates Newsletter Receive updates on funding opportunities from AFAR and the field.
More Funding Opportunities McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss Who is eligible: Independent Assistant and Associate Professors Research area: Cognitive Aging and Memory Loss Amount of award: $750,000 Number of awards given: Two Deadline for Letter of Intent: April 15, 2026 Hevolution Foundation Scientific Conferences Fund Who is eligible: Non-profit organizations, public and private universities, colleges, laboratories and government agencies in North America (Canada, United States of America, and Mexico), the United Kingdom, and countries in the European Union Amount of award: Up to $10,000 per meeting Deadline: January 31, April 30, July 31, October 31 Diana Jacobs Kalman/AFAR Scholarships for Research in the Biology of Aging Who is Eligible: MD, DO, PhD, or combined degree students who have completed at least two years by the start date of the scholarship Research Area: Biology of aging Scholarship Amount: $5,000 Program Period: 12 months Deadline: The deadline has passed for 2025 AFAR Grants for Junior Faculty and Glenn Foundation for Medical Research (GFMR) Grants for Junior Faculty Who is eligible: Independent Early Stage Investigators Research area: Biology of aging Amount of award: $160,000 Award period: 1 or 2 years Number of awards given: Approximately 10 Deadline for LOI: The deadline has passed for 2026 The Sagol Network GerOmic Award for Junior Faculty Who is eligible: Independent Junior Faculty Research area: Aging-related -omics research Amount of award: $160,000 Award period: 1 or 2 years Number of awards given: 1 Letter of Intent Deadline: The deadline has passed for 2026 Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research Who is Eligible: Postdoctoral fellows Research Focus: Basic and translational research that builds on early discoveries that show translational potential for clinical relevant strategies Letter of Intent Deadline : The deadline has passed for 2026 2025 Glenn Foundation for Medical Research Postdoctoral Fellowship Continuation Awards Who is Eligible: Current or former GFMR Postdoctoral Fellows in Aging Research Research Focus: Basic and translational research that builds on early discoveries that show translational potential for clinical relevant strategies Award Amount: $80,000 (a minimum of $62,652 is to be used for salary and the remainder to be used for allowable expenses) Letter of Intent Deadline : The deadline has passed for 2026 Glenn Foundation for Medical Research (GFMR) Discovery Award Who is Eligible: Full-time faculty at the rank of Assistant Professor or higher Research Focus: Biology of aging Letter of Intent Deadline: The deadline has passed for 2026 Medical Student Training in Aging Research (MSTAR) Program Who is Eligible: Any allopathic or osteopathic medical student in good standing, who will have successfully completed one year of medical school at a U.S. institution by June 2026.
Interested students should be in touch directly with the National Training Centers to determine their eligibility and program deadline. 55 West 39th Street, 16th Floor Toll-Free: (888) 582-2327
According to the current listing, eligibility includes: Clinically trained (primarily physician) early-stage investigators who have received competitively awarded research support as a PD/PI at faculty level and demonstrated leadership potential. Confirm the full requirements in the official notice before applying.
The current listing shows up to $225,000 direct costs per year for up to 5 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for AFAR Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76) are due June 13, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
AFAR Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76) is funded by American Federation for Aging Research. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research is sponsored by American Federation for Aging Research (AFAR) and Glenn Foundation for Medical Research. This fellowship supports postdoctoral scientists conducting research in aging. AFAR's grant programs are central to its mission to support and advance healthy aging through biomedical research.
AFAR Hevolution Foundation Scientific Conferences Fund is a grant from the American Federation for Aging Research (AFAR) that funds scientific conferences, symposia, and meetings advancing aging and longevity research. Awards of up to $10,000 are available per meeting, with larger amounts considered on a case-by-case basis. Eligible applicants include nonprofits, public and private universities, colleges, laboratories, and government agencies in North America (Canada, Mexico, USA), the United Kingdom, and EU countries. For-profit organizations and individual applicants are excluded. The program supports gatherings that advance geroscience, facilitate researcher collaboration, and disseminate findings to the broader aging research community. Applications are reviewed on a rolling basis.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article